Leaflet RIFAMPICINA 150mg capsules
Indicated for: tuberculosis
Route of administration: oral
Substance: rifampicin (anti-tuberculosis agent)
ATC: J04AB02 (Antiinfectives for systemic use | Drugs for treatment of tuberculosis | Antibiotics)
This medicine may affect the liver.
This medicine may have important interactions with other medicines.
Periodic laboratory tests may be required during treatment.
Use during pregnancy only on medical advice.
Rifampicin is an antibiotic primarily used to treat tuberculosis and other severe bacterial infections, such as leprosy or infections caused by Staphylococcus aureus. It belongs to the rifamycin class and works by inhibiting bacterial RNA synthesis, effectively killing the bacteria.
It is an essential medication in tuberculosis treatment, used in combination with other antibiotics to prevent bacterial resistance. Rifampicin is also used to prevent bacterial meningitis in individuals exposed to Neisseria meningitidis.
Side effects may include nausea, abdominal pain, orange discoloration of urine, tears, or saliva, and, more rarely, liver function impairment. Patients must strictly follow the prescribed treatment regimen to avoid the development of bacterial resistance.
Rifampicin should not be used without medical supervision, as it interacts with many other medications and may reduce their effectiveness.
General data about RIFAMPICINA 150mg
- Substance: rifampicin
- Date of latest medicines list: 01-01-2015
- Product code: W05438007
- Concentration: 150mg
- Pharmaceutical form: capsules
- Quantity: 1000
- Product type: Generic medicine
- Prescription status: S - Medicines dispensed with a restricted medical prescription, reserved for use in certain specialized fields.
Concentrations available for rifampicin
- 150mg
- 300mg